Profiles

Brooke Nichols

Assistant Professor, Global Health - Boston University School of Public Health

Biography

Brooke Nichols, PhD, MSc, is a health economist and infectious disease mathematical modeler. She holds a Bachelor of Arts from Mount Holyoke College in International Relations, a Master of Science from the University of Massachusetts Amherst in Epidemiology, and a PhD from the Erasmus Medical Center (Rotterdam, the Netherlands) in the economic and infectious disease modelling of HIV prevention strategies. Dr. Nichols’ research experience and interests include modelling and economic evaluation of treatment as prevention (HIV and HCV) and pre-exposure prophylaxis (HIV), HIV drug resistance modelling, geospatial modelling for efficient resource allocation, and translating research into public policy recommendations. Her recent work has focused on mathematical modeling of the COVID19 epidemic in South Africa and Zambia, with a specific focus on resource allocation and optimized molecular, rapid antigen, and serological testing strategies within constrained resources.

Education

  • Erasmus Universiteit Rotterdam, PhD Field of Study: Public Health
  • University of Massachusetts Amherst, MS Field of Study: Epidemiology
  • Mount Holyoke College, BA Field of Study: International Relations

Classes Taught

  • SPHPH720

Publications

  • Published on 5/4/2021

    Nichols BE, Jamieson L, Zhang SRC, Rao GA, Silal S, Pulliam JRC, Sanne I, Meyer-Rath G. The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity. Clin Infect Dis. 2021 05 04; 72(9):1642-1644. PMID: 32628744.

    Read At: PubMed
  • Published on 4/28/2021

    Chevalier J, Sy KTL, Girdwood SJ, Khan S, Albert H, Toporowski A, Hannay E, Carmona S, Nichols BE. Optimal use of COVID19 Ag-RDT screening at border crossings to prevent community transmission: a modeling analysis. medRxiv. 2021.

    Read At: Custom
  • Published on 4/21/2021

    Sy KTL, White LF, Nichols BE. Population density and basic reproductive number of COVID-19 across United States counties. PLoS One. 2021; 16(4):e0249271. PMID: 33882054.

    Read At: PubMed
  • Published on 4/1/2021

    Nichols BE, Cele R, Lekodeba N, Tukei B, Ngorima-Mabhena N, Tiam A, Maotoe T, Sejana MV, Faturiyele IO, Chasela C, Rosen S, Fatti G. Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients. J Int AIDS Soc. 2021 Apr; 24(4):e25692. PMID: 33838012.

    Read At: PubMed
  • Published on 3/26/2021

    Girdwood S, Hannay E, Kassa H, Albert H, Carmona S, Nichols BE. Quantifying Rapid Antigen Diagnostic Resource Requirements for SARS-CoV-2: A Cost-Effectiveness Analysis of Testing Strategies for Five Countries in Sub-Saharan Africa. SSRN. 2021.

    Read At: Custom
  • Published on 3/21/2021

    Jo Y, Rosen S, Sy KTL, Phiri B, Huber AN, Mwansa M, Shakwelele H, Haimbe P, Mwenechanya MM, Lumano Mulenga P, Nichols BE. Changes in HIV Treatment Differentiated Care Utilization During the COVID-19 Pandemic in Zambia. medRxiv. 2021.

    Read At: Custom
  • Published on 2/27/2021

    Rashid A, Sy KTL, Cabrejas JM, Nichols BE, Bhadelia N, Murray EJ. A clinician's primer on epidemiology for COVID-19. Med (N Y). 2021 Apr 09; 2(4):384-394. PMID: 33681831.

    Read At: PubMed
  • Published on 2/25/2021

    Popping S, Kall M, Nichols BE, Stempher E, Versteegh L, van de Vijver DAMC, van Sighem A, Versteegh M, Boucher CA, Delpech V, Verbon A. Quality of life among people living with HIV in England and the Netherlands comparable to the general population. SSRN. 2021.

    Read At: Custom
  • Published on 2/2/2021

    Nichols BE, Cele R, Jamieson L, Long LC, Siwale Z, Banda P, Moyo C, Rosen S. Community-based delivery of HIV treatment in Zambia: costs and outcomes. AIDS. 2021 02 02; 35(2):299-306. PMID: 33170578.

    Read At: PubMed
  • Published on 1/29/2021

    Jo Y, Jamieson L, Edoka I, Long L, Silal S, Pulliam JRC, Moultrie H, Sanne I, Meyer-Rath G, Nichols BE. Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa. Open Forum Infect Dis. 2021 Mar; 8(3):ofab040. PMID: 33732750.

    Read At: PubMed

News & In the Media